DIN 02192691 — 3TC 10 MG
3TC is a solution of Lamivudine marketed by VIIV HEALTHCARE ULC. The full Lamivudine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02192691
- Brand name
- 3TC
- Active ingredient
- Lamivudine
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- ORAL
- Manufacturer
- VIIV HEALTHCARE ULC
- Health Canada status
- MARKETED
- Drug class
- Nucleoside reverse transcriptase inhibitor (NRTI) / antiretroviral agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lamivudine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02192683 | 3TC | 150 MG | TABLET | VIIV HEALTHCARE ULC | MARKETED |
| 02247825 | 3TC | 300 MG | TABLET | VIIV HEALTHCARE ULC | MARKETED |
| 02369052 | APO-LAMIVUDINE | 150 MG | TABLET | APOTEX INC | MARKETED |
| 02369060 | APO-LAMIVUDINE | 300 MG | TABLET | APOTEX INC | MARKETED |
| 02393239 | APO-LAMIVUDINE HBV | 100 MG | TABLET | APOTEX INC | MARKETED |
| 02507110 | JAMP LAMIVUDINE | 150 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02507129 | JAMP LAMIVUDINE | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02512467 | JAMP LAMIVUDINE HBV | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |